Table of Contents
Washington University Experience | MYELIN (IMMUNE-MEDIATED) | MS - Tumefactive | 3C12 MS, Tumefactive (Case 3) Ki67 20X
In this case there are surprisingly few cells labeled with the proliferative marker Ki67. In some cases there are significant numbers of labeled cells which may encourage a misdiagnosis of neoplasm (Ki67 IHC)
